14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
Mar 24, 2020 $73.90 $80.62 $72.58 $80.14 603 888
Mar 23, 2020 $73.02 $74.66 $67.15 $70.82 745 720
Mar 20, 2020 $75.00 $75.57 $71.04 $72.00 871 833
Mar 19, 2020 $70.33 $75.24 $68.88 $74.62 622 916
Mar 18, 2020 $73.83 $78.19 $67.64 $70.91 826 922
Mar 17, 2020 $72.91 $78.24 $66.44 $77.69 1 029 197
Mar 16, 2020 $74.80 $78.31 $72.61 $72.64 833 466
Mar 13, 2020 $79.14 $81.61 $76.56 $81.59 757 914
Mar 12, 2020 $78.40 $83.22 $74.59 $74.70 736 518
Mar 11, 2020 $89.77 $90.86 $83.92 $84.39 580 028
Mar 10, 2020 $87.11 $92.07 $84.37 $91.60 518 688
Mar 09, 2020 $86.24 $89.99 $85.04 $85.29 822 503
Mar 06, 2020 $91.54 $94.67 $90.76 $91.33 505 923
Mar 05, 2020 $92.00 $95.48 $91.43 $94.06 431 733
Mar 04, 2020 $95.08 $95.77 $93.41 $93.79 591 510
Mar 03, 2020 $91.00 $97.56 $91.00 $92.67 937 954
Mar 02, 2020 $87.38 $90.30 $86.23 $89.77 560 150
Feb 28, 2020 $84.32 $91.41 $82.77 $85.64 880 648
Feb 27, 2020 $85.53 $90.59 $81.78 $86.57 541 599
Feb 26, 2020 $88.00 $89.84 $86.60 $87.36 282 813
Feb 25, 2020 $90.19 $91.65 $87.69 $88.19 339 258
Feb 24, 2020 $92.61 $93.04 $88.30 $90.20 429 098
Feb 21, 2020 $94.81 $95.10 $93.48 $94.51 362 352
Feb 20, 2020 $94.14 $95.21 $92.37 $94.85 264 062
Feb 19, 2020 $94.77 $95.89 $93.51 $94.44 324 793
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT